Another chance to get a second look at instrument performance. Over a year ago, we looked at cancer marker performance on the Vista. Now we examine a 2012 study that compared the method performance of the new Vista methods vs. the older Immulite methods. How do the two generations of Siemens instrumentation compare? Do those results match the other study?

Register to read more …